The anti-calcitonin gene-related peptide (CGRP) monoclonal antibody erenumab (Aimovig) helps patients with chronic migraine convert to an episodic pattern soon after treatment initiation, new research suggests. In an open-label study, 71% of patients with chronic migraine treated for 1 year converted to episodic migraine. “Erenumab is related to a remarkably high percentage of pattern reversal
What: The Brain Prize has been awarded to Michael A. Moskowitz, M.D., a professor of neurology at Harvard Medical School at the Massachusetts General Hospital, Charlestown, who also is supported by an NIH grant. The Brain Prize is "the world's most prestigious award for brain research" and is awarded by the Lundbeck Foundation, Denmark. Dr.
People with chronic migraines who use cannabis products are much more likely to suffer from “rebound headaches” than those who don’t use the drugs, a preliminary study suggests. However, though a link has been uncovered, it’s still unclear whether cannabis directly triggers the rebound headaches, the study authors told Live Science. The study also didn’t
Written by Kayleigh Dray Kayleigh Dray is Stylist’s digital editor-at-large. Her specialist topics include comic books, films, TV and feminism. On a weekend, you can usually find her drinking copious amounts of tea and playing boardgames with her friends. It’s not just you who feels unwell; here, a doctor explains why everyone is feeling under
It is estimated that one in seven people globally live with migraines. Migraines are recognised as a significant disorder which sufferers often experiencing intense symptoms that range from visual disturbance to vomiting, dizziness to vertigo. More than 90 per cent of people with migraines say they can not work or function normally due to the
An early assessment reveals that a newly approved drug to treat migraines does not seem effective among patients who suffer from high-frequency migraines. The findings will be presented this week during the 61st annual scientific meeting of the American Headache Society in Philadelphia. Clinicians at OHSU in Portland, Oregon, conducted a retrospective chart review of
New study: migraine overestimated-causing effects of red wine? According to health experts, about 15 percent of Germans suffer from migraine. Triggered the headache attacks may be a result of certain triggers. Also red wine is one of these. But a new study now provides evidence that the migraine was overestimated triggering effect of alcohol/red wine
Bright lights, certain smells, foods and drinks, exercise, stress, too much sleep, too little sleep: If any of these terms made you flinch, then you might be a might be a migraine sufferer. Migraines may feel like the pinnacle of pain, but what you may not know is, they actually can get worse. That’s why,
Does THIS explain why women are more likely to suffer migraine? Higher levels of oestrogen and other sex hormones are to blame for women suffering more migraines than men, reveal scientists Scientists were baffled as to why women are more vulnerable to migraine But a new Spanish review of medical literature finally offers hope of
In UK alone, chronic migraine affects more than six lakh people. And even though a number of treatment options exist to reduce the intensity of the symptoms, there is no definitive solution for it. The first drug to prevent migraine has been approved by European health officials. According to a report in The Guardian, the drug Erenumab
I was five years old when I had my first migraine. When my parents took me to the doctor, they told them these “headaches” would go away as I got older. They didn’t. As I got older, the migraines got worse. The debilitating pain would come at least once a week, and when I was
New once-a-month drug offers hope to millions with severe migraines (and it will be available next week) The injected medication Aimovig is due to be available within the next week Unlike other migraine drugs, it does not cause side effects like weight gain Side effects can be worse than migraines, with up to 86% stopping
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok